About: Exicure, Inc. does not have significant operations. Previously, it focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. The company has a co-development agreement with Adbiotech Co., Ltd. to explore combination therapies based on Burixafor (GPC-100) across multiple therapeutic areas. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $1.10 (+1.04%)
XCUR NASDAQ Exicure Inc
Loading watchlist status…
Exicure Inc share price
XCUR price activity
Last Price
$1.100
Change (24hr)
0.01 USD (1.04%)
Volume
13.47K
Volume (4w avg)
-
Open
$1.12
Day Range
$1.09 - $1.12
Previous Close
$1.09
Last Trade
13 Oct, 3:56 pm GMT+0
Delayed
13 Oct, 3:56 pm GMT+0
XCUR price performance
1.97%
5D
-21.34%
1M
-79.68%
YTD
-78.57%
1Y
Delayed
13 Oct, 3:56 pm GMT+0
XCUR Market Signals